New: the Income Securities Screening Form now screens by price, yield, S&P rating, call status and trading volume, and you can save your searches to run again. Try the updated form.
Standard BioTools, Inc. (LAB)
LAB · NGS · Common · CUSIP 34385P108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for LAB and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
34385P108 (prev. 343850103 )
IPO
2/10/2011 · 5.56 Million Shares @ $13.50/share
Prospectus
IPO prospectus »
Previous Symbol
FLOM (changed 4/5/2022)
Previous Name
Fluidigm Corp.
Business: Standard BioTools, Inc. is an industry-leading biotechnology tools provider with a vision to improve life through comprehensive health insight. The Company focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF and microfluidics technologies, the Comapany develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies.

Company Contact

CEO
Michael Egholm
CFO
Alex Kim
Headquarters
2 Tower Place, Suite 2000, South San Francisco, CA 94080
Phone
650-266-6000 · Toll-Free 866-359-4354
Fax
650-871-7152
Investor Relations
Agnes Lee · 650-416-7423 · agnes.lee@fluidigm.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »